Clouds. 74.3   F New York
AI-Powered News Summarizer
Top Stories

Glaxo, Sanofi to partner on $2 billion Operation Warp Speed coronavirus vaccine contract

July 31, 2020. Summarized by summa-bot.

Drug giants GlaxoSmithKline and Sanofi Pasteur said Friday they had won a commitment from the US federal government to pay up to $2.1 billion to help the two companies move forward with their proposed joint coronavirus vaccine as part of Operation Warp Speed.

(CNN)Drug giants GlaxoSmithKline and Sanofi Pasteur said Friday they had won a commitment from the US federal government to pay up to $2. 1 billion to help the two companies move forward with their proposed joint coronavirus vaccine as part of Operation Warp Speed.

The companies had said in April they would work together to make a vaccine against Covid-19, using Sanofi's flu vaccine technology and Glaxo's adjuvant -- a compound that boosts the power of a vaccine.

It's the largest funding announcement for an Operation Warp Speed vaccine so far.

"The portfolio of vaccines being assembled for Operation Warp Speed increases the odds that we will have at least one safe, effective vaccine as soon as the end of this year," US Health and Human Services Secretary Alex Azar said in a statement distributed by Glaxo.

Moncef Slaoui, chief adviser to Operation Warp Speed, told CNN's Elizabeth Cohen on Thursday that the program was going to fund eight different coronavirus vaccines.

Pfizer and its vaccine partner BioNTech have a $1. 95 billion deal with Operation Warp Speed; Novavax has a $1. 6 billion deal; AstraZeneca's contract is for $1. 2 billion; Moderna's awards total $900 million; and Johnson & Johnson subsidiary Janssen has a $450 million contract, according to HHS's Biomedical Advanced Research and Development Authority website.

Summarizer is on Google News. Now you can get the latest AI summarized news on your favorite news platform.

Don't like Google News? We have an RSS Feed for you.

Suggestions